FR2258853B1 - - Google Patents

Info

Publication number
FR2258853B1
FR2258853B1 FR7502129A FR7502129A FR2258853B1 FR 2258853 B1 FR2258853 B1 FR 2258853B1 FR 7502129 A FR7502129 A FR 7502129A FR 7502129 A FR7502129 A FR 7502129A FR 2258853 B1 FR2258853 B1 FR 2258853B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7502129A
Other languages
French (fr)
Other versions
FR2258853A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2258853A1 publication Critical patent/FR2258853A1/fr
Application granted granted Critical
Publication of FR2258853B1 publication Critical patent/FR2258853B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7502129A 1974-01-25 1975-01-23 Expired FR2258853B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH104774 1974-01-25

Publications (2)

Publication Number Publication Date
FR2258853A1 FR2258853A1 (enExample) 1975-08-22
FR2258853B1 true FR2258853B1 (enExample) 1978-06-30

Family

ID=4201215

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7502129A Expired FR2258853B1 (enExample) 1974-01-25 1975-01-23

Country Status (14)

Country Link
JP (1) JPS50106969A (enExample)
AT (1) ATA53175A (enExample)
AU (1) AU7756375A (enExample)
BE (1) BE824742A (enExample)
DE (1) DE2501468A1 (enExample)
DK (1) DK3375A (enExample)
ES (1) ES434079A1 (enExample)
FR (1) FR2258853B1 (enExample)
GB (1) GB1472342A (enExample)
IE (1) IE40368B1 (enExample)
IL (1) IL46505A0 (enExample)
NL (1) NL7500535A (enExample)
SE (1) SE7500262L (enExample)
ZA (1) ZA75522B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999186A (en) * 1986-06-27 1991-03-12 The Procter & Gamble Company Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
CA2407677A1 (en) * 2000-04-28 2002-10-28 Baxter Healthcare Sa 2-acyl indol derivatives and their use as anti-tumour agents
DE10152306A1 (de) * 2001-10-26 2003-07-24 Asta Medica Ag 2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
US20100298343A1 (en) * 2007-10-05 2010-11-25 John Howard Hutchinson 5-lipoxygenase-activating protein (flap) inhibitors
KR101763656B1 (ko) 2009-06-29 2017-08-01 인사이트 홀딩스 코포레이션 Pi3k 저해물질로서의 피리미디논
US8759359B2 (en) 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
TW201130842A (en) 2009-12-18 2011-09-16 Incyte Corp Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
EP2558463A1 (en) 2010-04-14 2013-02-20 Incyte Corporation Fused derivatives as i3 inhibitors
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
EP3660016A1 (en) 2010-12-20 2020-06-03 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
PT3513793T (pt) 2011-09-02 2021-05-10 Incyte Holdings Corp Heterociclilaminas como inibidores de pi3k
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
SG10201907576SA (en) 2015-02-27 2019-09-27 Incyte Corp Salts of pi3k inhibitor and processes for their preparation
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
SG11202011680YA (en) 2018-06-01 2020-12-30 Incyte Corp Dosing regimen for the treatment of pi3k related disorders

Also Published As

Publication number Publication date
DE2501468A1 (de) 1975-07-31
IE40368L (en) 1975-07-25
GB1472342A (en) 1977-05-04
IE40368B1 (en) 1979-05-09
AU7756375A (en) 1976-07-29
ATA53175A (de) 1977-08-15
IL46505A0 (en) 1975-04-25
DK3375A (enExample) 1975-09-15
JPS50106969A (enExample) 1975-08-22
BE824742A (fr) 1975-07-24
ES434079A1 (es) 1977-03-01
FR2258853A1 (enExample) 1975-08-22
ZA75522B (en) 1976-01-28
SE7500262L (enExample) 1975-07-28
NL7500535A (nl) 1975-07-29

Similar Documents

Publication Publication Date Title
FR2258853B1 (enExample)
DK128875A (enExample)
DK137969C (enExample)
AU7459074A (enExample)
AU7462274A (enExample)
AU6599874A (enExample)
DE2409641A1 (enExample)
CS174473B1 (enExample)
CS168320B1 (enExample)
BG19768A1 (enExample)
BG19673A1 (enExample)
CH587605A5 (enExample)
AU481360A (enExample)
BG21135A1 (enExample)
BG19999A1 (enExample)
BG19927A1 (enExample)
BG19872A1 (enExample)
BG19828A1 (enExample)
BG19825A1 (enExample)
BG19772A1 (enExample)
BG19959A1 (enExample)
BG19764A1 (enExample)
BG19746A1 (enExample)
BG19694A1 (enExample)
BG19692A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse